🇪🇺 Enlon-Plus in European Union

Enlon-Plus (ATROPINE) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006385
  • Local brand name: Atropine sulfate FGK
  • Status: refused

Enlon-Plus in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Ophthalmology approved in European Union

Frequently asked questions

Is Enlon-Plus approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Enlon-Plus in European Union?

Mmt is the originator. The local marketing authorisation holder may differ — check the official source linked above.